MyAlcon for Professionals Logo
MyAlcon for Consumer

MyAlcon | Caribbean

This page is available in English. Select below for other locations.

Select Another Location

AcrySof® IQ Monofocal and AcrySof® IQ Toric IOLs


The trusted IOL that gives you complete confidence

AcrySof® IQ Monofocal and AcrySof® IQ Toric IOLs

 

The trusted IOL that gives you complete confidence

 

AcrySof® IQ Monofocal IOLs Give You Complete Confidence You Made The Right Choice

 

Low PCO and Nd: YAG Rates1-8

Helps free-up capacity by helping to reduce secondary treatments

 

Excellent Quality of Vision1,9-12,16-23

Proven long-lasting visual outcomes

 

Trusted by Surgeons24,25

Over 125 million implants worldwide

3-dimensional image of a yellow AcrySof IQ Monofocal IOLs and a clear AcrySof IQ Monofocal IOLs side-by-side.

Extensive Research Proves AcrySof® Has Low Nd:YAG Rates at 3 and 5 years2*

Blue icon of a circle with multiple eyes inside. Blue text under the circle reads “Royal College of Ophthalmology & National Ophthalmology Database Unique Report. Study conducted on over 600,000 eyes.” Bar graph illustrating that in a study conducted on more than 600,000 eyes, AcrySof IQ showed reduced PCO and the lowest Nd:YAG rates at 3 and 5 years, compared to single-piece and hydrophilic IOLs.

Unprecedented data demonstrates AcrySof® Reduces Nd: YAG treatment4-8

Multiple studies conducted across various countries reveal why AcrySof® IQ should be the right IOL choice.

Visual chart highlighting data from multiple countries showing that AcrySof has the lowest Nd:YAG rates at 3 years, compared to other IOLs.
Three illustrations side-by-side. The first one has a blue icon of an eye with text that reads “4,730 eyes” underneath. Second one has a blue icon of a clipboard with text underneath that reads “37 RCTs.” The last one has blue text that reads “AcrySof 2.7x lower risk of Nd:YAG vs other hydrophobic IOLs.” Above these three illustrations, blue text reads “randomized controlled trials.”

Reduced development of PCO

 

AcrySof® IQ material promotes clear capsules and reduces secondary treatments:1,3

 

  • Unique AcrySof® IQ hydrophobic acrylic material provides the highest bonding with the capsule compared to competitor IOLs.*
  • Proprietary edge design helps to block cell migration between the optic and the capsular bag.

 

*compared to PMMA, HOYA, and TECNIS IOLs, n=32 IOLs per group, P<0.001

2 illustrations. The first one shows the AcrySof IOL bonded with the posterior capsul with not cell migration. The second illustration shows other IOLs with cells migrating between the optic and posterior capsule.

Excellent Quality of Vision

 

AcrySof® IQ BioMechanics provide excellent refractive outcomes

Illustration showing how STABLEFORCE Haptics allow AcrySof IQ IOLs to fit in any capsular bag size: 10.5 mm, 10.0 mm, 9.5 mm, 9.0 mm. Two illustrations. The first is an illustration of an AcrySof IQ IOL. A light blue circle is placed on the centre of the IOL to draw focus. A light blue line is connected to the IOL with text that reads “AcrySof IQ Centered.” The second is an illustration of other generic IOLs. A light blue line is connected to the IOL with text that reads “Other IOL Decentered.” Smaller text underneath reads “When haptics cannot adapt to bag size, they push the IOL off the center as bag shrinks.” 2 images illustrating how AcrySof IQ IOL has greater axial stability than enVisto MX60, which helps to reduce refractive errors.

*Trademarks are the property of their respective owners.

Available in two filtering properties that mimic the natural human lens1,16,18

UV and Blue light filter

 

Proprietary chromophore that can help filter harmful light sources, similar to the healthy human lens1,18

 

The AcrySof® IQ blue light filter can provide patients with a greater tolerance for extreme bright light as well as faster visual recovery after high bright light exposure1,16-19

3-dimensional image of a yellow AcrySof IQ Monofocal IOLs and a clear AcrySof IQ Monofocal IOLs side-by-side.
3-dimensional image of a yellow AcrySof IQ Monofocal IOLs and a clear AcrySof IQ Monofocal IOLs side-by-side.

UV filter
 

AcrySof® provides amongst the highest level of UV radiation filter. Some IOLs allow parts of UVA radiation to pass through the IOL and to the retina.1,12-15

*Other IOLs include J&J Tecnis†, and B&L Envista†. See UV filter chart below for further details.

†Trademarks are the property of their respective owners.

AcrySof® blue light filter helps patients manage conditions they encounter every day.1,16-19*†

 

  • Greater tolerance for extreme bright light16,18,19
  • Faster visual recovery after high bright light exposure16,18,19

 

Improved Performance in Challenging Conditions*

Illustration showing a car labelled as AcrySof IQ IOL and a car labelled as non-blue light filtering IOL. Text on screen reads, “40+ metres (~3 school buses) stopping distance at 88 km/h.”

*A subset of patients (n = 44) underwent testing in a validated night driving simulator. Patients were tested monocularly under conditions which simulate city and rural settings under normal, glare and fog conditions.

†AcrySof® IQ IOL patients had an average increase of 40+ metres feet versus the control lens in which to stop after identifying a warning sign in a rural setting under fog conditions at 88 km/h.

High Level of UV Protection1

AcrySof® provides amongst the highest level of UV radiation filter close to the 400nm cutoff1,12-15,23

Bar chart illustrates how AcrySof is the only IOL that provides 100% UV light protection. Other IOLs provide incomplete UV light protection.

Fully usable optic helps reduce visual disturbances

 

The AcrySof® IQ aspheric optic surface is designed to reduce edge glare.1

Close up of an AcrySof IQ IOL with letters behind it, showing full use of the 6mm aspheric optic
Close up of an AcrySof IQ IOL with letters behind it, showing full use of the 6mm aspheric optic
AcrySof® (SN60WF)

 

6 mm fully usable aspheric optic1,20

Close up of an Tecnis 1-piece IOL with letters behind it, showing limited use of the 4.9 mm aspheric optic.
Close up of an Tecnis 1-piece IOL with letters behind it, showing limited use of the 4.9 mm aspheric optic.
TECNIS* 1-Piece (ZCB00)

 

4.9 mm limited usable aspheric optic13,20

Close up of an enVista IOL with letters behind it, showing limited use of the 4.9 mm aspheric optic.
Close up of an enVista IOL with letters behind it, showing limited use of the 4.9 mm aspheric optic.
enVista* (MX60)

 

4.9 mm limited usable aspheric optic15,20

*Trademarks are the property of their respective owners

Trusted by Surgeons Worldwide

 

AcrySof® IQ features proven technology for a confidence that has been truly earned.

White icon of a trophy on a blue circle.
White icon of a trophy on a blue circle.

RANKED #1

in surgical IOLs24

Illustration of an AcrySof IQ IOL on a blue circle.
Illustration of an AcrySof IQ IOL on a blue circle.

125+ MILLION

AcrySof® IOLs implanted worldwide25

Large white text that reads “25+” on a blue circle.
Large white text that reads “25+” on a blue circle.

25+ YEARS

proven safety and effectiveness

White icon of a folder on a blue circle.
White icon of a folder on a blue circle.

BACKED BY

unprecedented clinical data

AcrySof® IQ is available in the UltraSert® Preloaded Delivery System

Learn More About UltraSert®
UltraSert Preloaded Delivery System.

 

Proven Stability and Exceptional Performance with AcrySof® IQ Toric IOL

Pie chart showing that 91.9% of AcrySof IQ Toric IOLs are within 5° of post-operative alignment. The majority of the circle is blue, and the remaining part is white
 

AcrySof® IQ Toric IOLs had significantly lower incidence of repositioning compared to other IOLs27*

 

Based on Retrospective comparison to TECNIS* Toric and HOYA 355 Toric Intraocular lens, (n=9430 eyes, p<0.0001)

Three white icons of an IOL with haptics placed at various angles to indicate rotation. Text in the centre of the lens reads, “TECNIS Toric IOLs are 8 times more likely to require repositioning.”

Alcon Online Toric IOL Calculator features the Barrett Algorithm

Launch Alcon Toric Calculator
Open laptop with the Alcon Online Toric IOL Calculator featured on the screen.

AcrySof IQ and Toric IOL Clinical Studies

Gunderson KG & Potvin R. Comparing visual acuity, low contrast acuity and refractive error after implantation of a low cylinder power toric intraocular lens or a non-toric intraocular lens

 

Comparing uncorrected and best-corrected visual acuity, low contrast acuity, residual refraction and ocular biometry after low cylinder power toric intraocular lens (IOL) or non-toric IOL implantation

Kramer BA, Hardten DR & Berdahl JP. Rotation characteristics of three toric monofocal intraocular lenses

 

Evaluating the rotational stability of the three monofocal toric intraocular lenses (IOLs) via data from an online toric IOL back-calculator

Hayashi K, Yoshida M, Hayashi S & Yoshimura K. Short-term changes in prediction error after cataract surgery in eyes receiving 1 of 3 types of single-piece acrylic intraocular lenses

 

Comparing short-term changes in refractive prediction error (PE) after phacoemulsification among eyes receiving different types of single-piece acrylic intraocular lenses (IOLs)

Ursell PG, Dhariwal M, O’Boyle D et al. 5 year incidence of YAG capsulotomy and PCO after cataract surgery with single-piece monofocal intraocular lenses: A real-world evidence study of 20,763 eyes

 

Evaluating the 3- and 5-year incidence of PCO and Nd:YAG capsulotomy in patients following cataract surgery, comparing results for different single-piece acrylic hydrophilic and hydrophobic monofocal IOL models and other patient factors

The Royal College of Ophthalmologists. National Ophthalmology Database Audit: Feasibility study of post-cataract posterior capsule opacification

 

Attempting to determine the risk factors for the development of PCO, and to explore the feasibility of periodic reporting and comparison of PCO rates for individual IOL models, IOL material, type of IOL and contributing centres

Technical Specifications1
 

 

ACRYSOF® IQ MONOFOCAL

Table with ACRYSOF IQ IOL

ACRYSOF® IQ TORIC

Acrysof IQ Toric table

*This number represents a 2020 update using this SRK/T formula. Unless otherwise noted, this suggested A-constant is presented as a guideline and is a starting point for implant power calculations.

Table AcrySof IQ Toric IOL second

ACRYSOF® SINGLE PIECE

Table ACRYSOF® Single Piece IOL​

ACRYSOF® MULTIPIECE

Table AcrySof® Multipiece

Instructions for Use (IFU)

 

For a full list of indications, contraindications and warnings, please visit ifu.alcon.com and refer to the relevant product’s instructions for use.

Visit IFU Database

Alcon Experience Academy

 

For relevant training content from industry thought leaders

Visit AEA Portal

References:

1. AcrySof® IQ Directions For Use.

2. RCOphth National Ophthalmology Database Audit Feasibility Study of Post-cataract Posterior Capsule Opacification https://www.nodaudit.org.uk/u/docs/20/rijbxkcubs/RCOphth%20NOD%20PCO%20Report%202021.pdf Accessed 14 July 2021.

3. Ong M, Wang L, Karakelle M. Fibronectin adhesive properties of various intraocular lens materials. Alcon Laboratories, Fort Worth, TX, USA. ARVO 2013.

4. Ursell PG, Dhariwal M, Majirska K, Ender F, Kalson-Ray S, Venerus A, Miglio C, Bouchet C. Three-year incidence of Nd:YAG capsulotomy and posterior capsule opacification and its relationship to monofocal acrylic IOL biomaterial: a UK Real World Evidence study. Eye (Lond). 2018 Oct;32(10):1579-1589.

5. Belda J, Placeres J, Elvira J, O’Boyle D, Puig X, Vives CP, et al. Is Nd:YAG capsulotomy incidence influenced by IOL biomaterial? Real-word evidence from Spain at 3 & 5 years after cataract surgery. Free Paper presented at the European Society of Cataract and Refractive Surgeons annual meeting; October 2020; Virtual Congress.

6. Lindholm JM, Laine I, Tuuminen R. Five-Year Cumulative Incidence and Risk Factors of Nd:YAG Capsulotomy in 10 044 Hydrophobic Acrylic 1-Piece and 3-Piece Intraocular Lenses. Am J Ophthalmol. 2019 Apr;200:218-223.

7. Thom H, Ender F, Samavedam S, Perez Vivez C, Gupta S, Dhariwal M, de Haan J, O'Boyle D. Effect of AcrySof versus other intraocular lens properties on the risk of Nd:YAG capsulotomy after cataract surgery: A systematic literature review and network meta-analysis. PLoS One. 2019 Aug 19;14(8):e0220498.

8. Ursell PG, Dhariwal M, O'Boyle D, Khan J, Venerus A. 5 year incidence of YAG capsulotomy and PCO after cataract surgery with single-piece monofocal intraocular lenses: a real-world evidence study of 20,763 eyes. Eye (Lond). 2020 May;34(5):960-968.

9. Wirtitsch MG, Findl O, Menapace R, Kriechbaum K, Koeppl C, Buehl W, Drexler W. Effect of haptic design on change in axial lens position after cataract surgery. J Cataract Refract Surg. 2004 Jan;30(1):45-51.

10. Nejima R, Miyai T, Kataoka Y, Miyata K, Honbou M, Tokunaga T, Kawana K, Kiuchi T, Oshika T. Prospective intrapatient comparison of 6.0-millimeter optic single-piece and 3-piece hydrophobic acrylic foldable intraocular lenses. Ophthalmology. 2006 Apr;113(4):585-90.

11. Kohnen T, Klaproth OK. Incision sizes before and after implantation of SN60WF intraocular lenses using the Monarch injector system with C and D cartridges. J Cataract Refract Surg. 2008 Oct;34(10):1748-53.

12. Mainster MA. Spectral transmittance of intraocular lenses and retinal damage from intense light sources. Am J Ophthalmol. 1978 Feb;85(2):167-70.

13. Tecnis 1-piece IOL with the Tecnis iTec Preloaded Delivery System Directions For Use. Johnson & Johnson Vision.

14. HOYA NY-60 Direction For Use. HOYA Corporation.

15. EnVista hydrophobic acrylic intraocular lens Directions For Use. Bausch & Lomb.

16. Gray R, Perkins SA, Suryakumar R, Neuman B, Maxwell WA. Reduced effect of glare disability on driving performance in patients with blue light-filtering intraocular lenses. J Cataract Refract Surg. 2011 Jan;37(1):38-44.

17. Wei X, She C, Chen D, Yan F, Zeng J, Zeng L, Wang L. Blue-light-blocking intraocular lens implantation improves the sleep quality of cataract patients. J Clin Sleep Med. 2013 Aug 15;9(8):741-5.

18. Landers JA, Tamblyn D, Perriam D. Effect of a blue-light-blocking intraocular lens on the quality of sleep. J Cataract Refract Surg. 2009 Jan;35(1):83-8.

19. Hammond BR Jr, Renzi LM, Sachak S, Brint SF. Contralateral comparison of blue-filtering and non-blue-filtering intraocular lenses: glare disability, heterochromatic contrast, and photostress recovery. Clin Ophthalmol. 2010;4:1465-1473.

20. Alcon Data on File, 2017. TDOC-0053803 - Imaging of the Usable Optic Diameter of Clareon SY60WF, Tecnis ZCB00, and enVista MX60 Intraocular Lenses.

21. Lane, S, Collins, S, Das, K et al. Evaluation of intraocular lens mechanical stability. J Cataract Refract Surg. 2019;45(4):501-506.

22. Alcon Data on File, 2017. TDOC-0054422 - Axial Displacement Images at 9mm Compression.

23. García-Domene MC, Pérez-Vives C, Peris-Martínez C, Artigas JM. Comparison of the Ultraviolet Light Filtering across Different Intraocular Lenses. Optom Vis Sci. 2018 Dec;95(12):1129-1134.

24. Based on 2020 sales reported in Market Scope, GfK, Nielsen, IQVIA, Euromonitor, and Alcon internal estimates.

25. Alcon sales data since 1993.

26. Oshika T, Fujita Y, Hirota A, et al. Comparison of incidence repositioning surgery to correct misalignment with three toric intraocular lenses. Eur J Ophthalmol. 2019. doi:10.1177/1120672119834469.

27. Lee BS, Chang DF. Comparison of the rotational stability of two toric intraocular lenses in 1273 consecutive eyes. Ophthalmology. 2018;125(9):1325-1331.

 

Please refer to the relevant product direction for use for list of indications, contraindications and warnings

"Exclusive Use For Health Care Professionals"

©2024 Alcon Inc. CAR-ACI-2400001